VAERS reports by lot

GSK DTaP/Tdap lot 33T42: VAERS reports

31 VAERS reports list lot 33T42 as a GSK DTaP/Tdap vaccine, received between 2018-09-07 and 2019-07-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
3%
Marked serious
1
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2025%
Neurological1418%
Dermatological (non-injection-site)1215%
General / Systemic (non-local)1114%
Allergic / Anaphylactic911%
Musculoskeletal68%
Respiratory45%
Cardiac / Cardiovascular22%
Gastrointestinal22%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas4
Arizona3
Florida3
Illinois2
New York2
North Carolina2
California2
Ohio1
Pennsylvania1
U.S. Virgin Islands1
South Carolina1
Kansas1

Reports by month received

2018-096
2018-105
2018-112
2018-125
2019-014
2019-024
2019-041
2019-052
2019-072

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.